Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Jana Sena MPTC woman contestant dies of cardiac arrest hours ahead of votes counting in East Godavari

A pall of gloom descended on her panchayat as the death left her supporters in shock.

Jana Sena MPTC woman contestant dies of cardiac arrest hours ahead of votes counting in East Godavari

A 28-year-old female candidate from the Jana Sena Party faced an untimely demise in East Godavari district of Andhra Pradesh. Garapati Divya, the MPTC contestant, passed away due to cardiac arrest just hours before the voting results were to be announced at Damanthunigidem Panchayat in Devarapalli Mandal. Divya's condition deteriorated on Friday evening following a complaint of chest pain, leading to her admission in a private hospital.

Her death has left her supporters in shock and brought a sense of sadness to her panchayat. As her family prepares for the last rites scheduled for Saturday morning, the counting of her votes is still ongoing. The outcome of this panchayat is eagerly awaited by the residents.

Written by urgent.news from The Hindu's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at thehindu.com →

More in Health & Medicine

Declare Drugs Insecurity in Country, Pharmacists Urge FG

Worried by the rising cases of drug diversion, illicit trafficking and counterfeit medicines which have serious consequences in the healthcare services, the Pharmaceutical Society of Nigeria (PSN) has…

  • Federal government urged to declare pharmaceutical insecurity in Nigeria
  • Drug diversion, illicit trafficking, and counterfeit medicines threaten healthcare
  • PSN President calls for direct government supervision of pharmaceutical supply chain

US regulator investigates tumour risk in children given Novartis gene therapy

The US Food and Drug Administration said on Friday it was investigating a risk of neoplasia, or tumour formation including malignancy, associated with Novartis’ gene therapy Zolgensma. The Swiss drug maker earlier in the day disclosed two cases in which tumours in children showed evidence of being linked to its gene therapy drug used to…

More from Saturday 7 November →